Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: Lessons learned from 115 consecutive patients

Circulation

Volumn 106, Issue 13 SUPPL., 2002, Pages

  Tweddell, James S ^a   Hoffman, George M ^a   Mussatto, Kathleen A ^a   Fedderly, Raymond T ^a   Berger, Stuart ^a   Jaquiss, Robert D B ^a   Ghanayem, Nancy S ^a   Frisbee, Stephanie J ^a   Litwin, S Bert ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

Author keywords

Autonomic nervous system; Cardiac output; Circulatory control; Heart defects, congenital

Indexed keywords

ANTIINFLAMMATORY AGENT; APROTININ; PHENOXYBENZAMINE;

AGED; ARTICLE; BLOOD FLOW VELOCITY; CARDIOPULMONARY BYPASS; FEMALE; HEART AFTERLOAD; HEART ARREST; HEART OUTPUT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXIMETRY; PALLIATIVE THERAPY; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME; ULTRAFILTRATION;

ANASTOMOSIS, SURGICAL; ANTI-INFLAMMATORY AGENTS; AORTA; APROTININ; FEMALE; FOLLOW-UP STUDIES; HEART ARREST, INDUCED; HOSPITALIZATION; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT, NEWBORN; MALE; MODELS, CARDIOVASCULAR; OXIMETRY; PALLIATIVE CARE; PHENOXYBENZAMINE; POSTOPERATIVE PERIOD; PULMONARY ARTERY; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0037167689     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pigott JD, Murphy JD, Barber G, et al. Palliative reconstructive surgery for hypoplastic left heart syndrome, Ann Thorac Surg. 1988;45:122-128.
2. Fraser CD Jr., Mee RB. Modified Norwood procedure for hypoplastic left heart syndrome, Ann Thorac Surg. 1995;60(6 suppl):S546-S549.
3. Pigula FA, Nemoto EM, Griffith BP, et al. Regional low-flow perfusion provides cerebral circulatory support during neonatal aortic arch reconstruction. J Thorac Cardiovasc Surg. 2000;119:331-339.
4. Jobes DR, Nicolson SC, Steven JM, et al. Carbon dioxide prevents pulmonary overcirculation in hypoplastic left heart syndrome. Ann Thorac Surg. 1992;54:150-151.
5. Tweddell JS, Hoffman GM, Fedderly RT, et al. Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg. 1999;67:161-168.
6. Tweddell JS, Hoffman GM, Fedderly RT, et al. Patients at risk for low systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg. 2000;69:1893-1899.
7. Mavroudis C, Gevitz M, Ring WS, et al. The Society of Thoracic Surgeons National Congenital Heart Surgery Database Report: analysis of the first harvest (1994-1997). Ann Thorac Surg. 1999;68:601-624.
8. Mahle WT, Spray TL, Gaynor JW, et al. Unexpected death after reconstructive surgery for hypoplastic left heart syndrome. Ann Thorac Surg. 2001;71:61-65.
9. Azakie T, Merklinger SL, McCrindle BW, et al. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience. Ann Thorac Surg. 2001;72:1349-1353.
10. Fogel MA, Rychik J, Vetter J, et al. Effect of volume unloading surgery on coronary flow dynamics in patients with aortic atresia. J Thorac Cardiovasc Surg. 1997;113:718-726; discussion 726-727.
11. Hoffman GM, Ghanayem NS, Stuth E, et al. Differences in anaerobic threshold predict mid-term survival after the Norwood operation for hypoplastic left heart syndrome. Cardiology in the Young. 2001;11(suppl 1):57.
12. Perioperative care. In: Castafieda AR, Jonas RA, Mayer JE, et al. Cardiac Surgery of the Neonate and Infant. Philadelphia, Pa: W. B. Saunders Co; 1994;80-82.
13. Barnea O, Austin EH, Richman B, et al. Balancing the circulation: theoretic optimization of pulmonary/systemic flow ratio in hypoplastic left heart syndrome. J Am Coll Cardiol. 1994;24:1376-1381.
14. Taeed R, Schwartz SM, Pearl JM, et al. Unrecognized pulmonary venous desaturation early after Norwood palliation confounds Qp:Qs assessment and compromises oxygen delivery. Circ. 2001;103:2699-2704.
15. Tweddell JS, Hoffman GM, Ghanayem NS, et al. Ventilatory control of pulmonary vascular resistance is not necessary to achieve a balanced circulation in the postoperative Norwood patient. Circ. 1999;100(18 suppl):I-671.
16. Hoffman GM, Ghanayem NS, Mussatto KA, et al. Phenoxybenzamine prevents hemodynamic deterioration at high arterial saturation in neonates after the Norwood procedure for HLHS. Cardiol Young. 2001; 11(suppl 1):146.
17. Tabbutt S, Ramamoorthy C, Montenegro LM, et al. Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation. Circ. 2001;104(12 suppl 1):I159-I164.
18. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg. 2001;71:745-754.
19. Murkin JM. Cardiopulmonary bypass and the inflammatory response: a role for serine protease inhibitors? J Cardiothorac Vasc Anesth. 1997;11(2 suppl 1):19-23.
20. Levy JH, Pifarre R, Schaff HV, et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation. 1995;92:2236-2244.
21. Cosgrove DM III, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg. 1992;54:1031-1036.
22. Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg. 1994;58:146-153.
23. Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion. 1991;6:41-50.
24. Gaynor JW. Use of modified ultrafiltration after repair of congenital heart defects. Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann. 1998;1:81-90.